Vijay Gorantla to Tacrolimus
This is a "connection" page, showing publications Vijay Gorantla has written about Tacrolimus.
Connection Strength
1.767
-
Schnider JT, Weinstock M, Plock JA, Solari MG, Venkataramanan R, Zheng XX, Gorantla VS. Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. Clin Dev Immunol. 2013; 2013:495212.
Score: 0.424
-
Elgendy TY, Waldner M, Zhang W, Kim DY, Minervini MI, Komatsu C, Kulahci Y, Washington KM, Gorantla VS, Ezzelarab MB, Solari MG, Thomson AW. Tacrolimus before CTLA4Ig and rapamycin promotes vascularized composite allograft survival in MGH miniature swine. Transpl Immunol. 2022 Dec; 75:101696.
Score: 0.205
-
Feturi FG, Unadkat JV, Zhang W, Hag ME, Wang Y, Komatsu C, Grybowski D, Zhang Z, Erbas V, Sahin H, Mcclaine S, Oksuz S, Plock J, Gorantla VS, Washington KM, Solari MG, Venkataramanan R, Spiess AM. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity. Pharm Res. 2022 Sep; 39(9):2179-2190.
Score: 0.204
-
Fries CA, Lawson SD, Wang LC, Slaughter KV, Vemula PK, Dhayani A, Joshi N, Karp JM, Rickard RF, Gorantla VS, Davis MR. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study. PLoS One. 2019; 14(1):e0210914.
Score: 0.160
-
van der Merwe Y, Faust AE, Conner I, Gu X, Feturi F, Zhao W, Leonard B, Roy S, Gorantla VS, Venkataramanan R, Washington KM, Wagner WR, Steketee MB. An Elastomeric Polymer Matrix, PEUU-Tac, Delivers Bioactive Tacrolimus Transdurally to the CNS in Rat. EBioMedicine. 2017 Dec; 26:47-59.
Score: 0.148
-
Unadkat JV, Schnider JT, Feturi FG, Tsuji W, Bliley JM, Venkataramanan R, Solari MG, Marra KG, Gorantla VS, Spiess AM. Single Implantable FK506 Disk Prevents Rejection in Vascularized Composite Allotransplantation. Plast Reconstr Surg. 2017 Feb; 139(2):403e-414e.
Score: 0.140
-
Kostereva NV, Wang Y, Fletcher DR, Unadkat JV, Schnider JT, Komatsu C, Yang Y, Stolz DB, Davis MR, Plock JA, Gorantla VS. IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation. PLoS One. 2016; 11(6):e0156149.
Score: 0.133
-
Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. Transplantation. 2015 Sep; 99(9):1765-73.
Score: 0.126
-
Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, Metes DM, Donnenberg AD, Shores JT, Dimartini AF, Kiss JE, Imbriglia JE, Azari K, Goitz RJ, Manders EK, Nguyen VT, Cooney DS, Wachtman GS, Keith JD, Fletcher DR, Macedo C, Planinsic R, Losee JE, Shapiro R, Starzl TE, Lee WP. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013 Feb; 257(2):345-51.
Score: 0.106
-
Perez-Abadia G, Laurentin-Perez L, Gorantla VS, Francois CG, Vossen M, Brouha PC, Orhun HI, Anderson GL, Maldonado C, Pidwell DJ, Breidenbach WC, Barker JH. Low-dose immunosuppression in a rat hind-limb transplantation model. Transpl Int. 2003 Dec; 16(12):835-42.
Score: 0.055
-
Wang H, Sobral MC, Snyder T, Brudno Y, Gorantla VS, Mooney DJ. Clickable, acid labile immunosuppressive prodrugs for in vivo targeting. Biomater Sci. 2020 Jan 01; 8(1):266-277.
Score: 0.042
-
Wachtman GS, Wimmers EG, Gorantla VS, Lin CH, Schneeberger S, Unadkat JV, Zheng XX, Brandacher G, Lee WP. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. Transplant Proc. 2011 Nov; 43(9):3541-4.
Score: 0.024